CXCL8 and chronic obstructive pulmonary disease: In another study of COPD, the authors found that tiotropium could reduce IL-17A induced CXCL8 release and eliminate inflammation, indicating the potential of anti-cholinergic therapy in controlling COPD (Meurs et al., 2013).